News

Blood Clotting Proteins Discovered as Biomarkers of Lupus Nephritis

By: 

Laurie Fickman
Lupus nephritis is one of the most frequent and severe clinical manifestations of lupus, representing a leading cause of morbidity and mortality. Photo courtesy: GettyImages
Lupus nephritis is one of the most frequent and severe clinical manifestations of lupus, representing a leading cause of morbidity and mortality. Photo courtesy: GettyImages
Hugh Roy and Lillie Cranz Cullen Endowed professor of biomedical engineering Chandra Mohan reports that clotting proteins are elevated in the urine of patients with lupus nephritis.
Hugh Roy and Lillie Cranz Cullen Endowed professor of biomedical engineering Chandra Mohan reports that clotting proteins are elevated in the urine of patients with lupus nephritis.

Finding Could Lead to Better Clinical Disease Monitoring

 

University of Houston researcher Chandra Mohan is reporting in Arthritis Research and Therapy that clotting proteins, both those that promote blood clots (pro-thrombotic) and those that work to dissipate them (thrombolytic), are elevated in the urine of patients who suffer from lupus nephritis (LN).

“Among the proteins examined, urine plasmin emerged as the strongest independent predictor of kidney function and renal disease status,” reports Mohan, Hugh Roy and Lillie Cranz Cullen Endowed professor of biomedical engineering at the UH Cullen College of Engineering. “Urine biomarkers represent promising candidates for the early diagnosis as well as the monitoring of disease activity and therapeutic responses in lupus nephritis.” The discovery of the new biomarker for active LN opens the door for clinical monitoring of the disease.

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body attacks its own tissues and organs. Inflammation from the disease can impact many different parts of the body including joints, skin, kidneys, blood cells, brain and heart. Lupus nephritis is one of the most frequent and severe clinical manifestations of SLE, representing a leading cause of morbidity and mortality.

New immunosuppressive drugs and biologics have brought improvements in recent SLE and LN survival rates, but early diagnosis and monitoring disease flares are still challenges that need to be addressed. Renal biopsy remains the gold standard for the diagnosis and prognosis of LN, but it’s invasive and cannot be used for routine monitoring of disease activity and treatment responses. Because of this, several studies focusing on screening and identifying non-invasive biomarkers for the early diagnosis and monitoring of SLE and LN are emerging.

Because coagulation system disorders have been reported in SLE and lupus nephritis patients and the frequency of thrombotic events was documented to be higher in SLE patients than in the general population, Mohan’s lab examined urinary proteins related to coagulation.

Finding elevations in both pro-thrombotic and thrombolytic proteins in the urine of patients with lupus nephritis was unexpected.

“When I first saw the presence of both I thought ‘This can’t be right, so let’s look at this in more detail with more urine samples and better assays,’” said Mohan, who describes the presence of both proteins as “a raging war” within the kidneys. If one or the other predominates, he said, there are medicines that can regulate the clotting in balance, but when both processes are equally upregulated, balancing this biological process becomes clinically challenging.

Urine samples for this study were obtained from 113 patients with LN who had previously been recruited from the renal clinic at UT Southwestern Medical Center between 2007 and 2011. Collaborating with Mohan on the study are lead author, Qing Ling, a practicing nephrologist, Michelle A. Petri, director of the Hopkins Lupus Center at Johns Hopkins Medicine, Baltimore, and Ramesh Saxena, professor of internal medicine –nephology at UT Southwestern Medical Center, Dallas.

Other recent Lupus research conducted by Chandra Mohan:

Researchers Developing Early Detection, Home Monitoring Tests for Lupus Nephritis

Deconstructing Lupus – Could Some of its Makeup Be Part of its Cure?

Faculty: 

Department/Academic Programs: 

Tag: 

Related News Stories

23 honored with 2020-21 Faculty and Student Excellence Awards

The W.T. Kittinger Teaching Excellence Award is traditionally the highest teaching award given in the College. It recognizes outstanding teaching and service to students. This year's recipient is Di Yang of Mechanical Engineering.

The Cullen College of Engineering at the University of Houston and Dr. Joseph W. Tedesco, Ph.D., P.E., the Elizabeth D. Rockwell Endowed Chair and Dean, are pleased to share the 2020-21 Faculty and Student Excellence Award winners.

The initial announcement was made during the virtual Spring 2021 State of the College Address on May 4.

21 Cullen College students receive SURF opportunities

A group of 21 students from the Cullen College of Engineering have been selected for the University of Houston's Summer Undergraduate Research Fellowships.

The Cullen College of Engineering is proud to announce that 21 undergraduate students have been selected for the University of Houston's Summer Undergraduate Research Fellowship (SURF), according to the Honors College.

UH, HCC partnering on Engineering Academy at Fraga campus

An exterior shot of the flags flying at the Houston Community College's Fraga Campus. The University of Houston's Cullen College of Engineering and HCC will be partnering to create an Engineering Academy on the campus.

The University of Houston's Cullen College of Engineering and Houston Community College have reached an agreement to offer UH Engineering Academy courses at the HCC Felix Fraga Academic Campus on the east side of Houston on Navigation Boulevard.

Upcoming Events / Seminars